glp 1 and stroke Risk of major adverse cardiovascular events associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis Stroke comparison: GLP-1 vs SGLT-2.
Description
For any of the used tests, results were considered as statistically significant if p-value 0.050
doi: 10.1016/s0167-0115(98)00155-4
34 (9): 12341247.e9
While this area requires further research, initial findings support the notion that GLP-1 RAs do not significantly compromise muscle quality or performance
Its been moving toward more mindful eating and drinking
Losing weight can lead to some loss of muscle as well as fat
